Page last updated: 2024-10-31

metyrapone and Obesity, Morbid

metyrapone has been researched along with Obesity, Morbid in 1 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Obesity, Morbid: The condition of weighing two, three, or more times the ideal weight, so called because it is associated with many serious and life-threatening disorders. In the BODY MASS INDEX, morbid obesity is defined as having a BMI greater than 40.0 kg/m2.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
BENEDETTI, A1
BUSONERA, G1

Other Studies

1 other study available for metyrapone and Obesity, Morbid

ArticleYear
[EFFECT OF A PROLONGED FAST ON HYPOPHYSIAL CORTICOTROPIN ACTIVITY IN SIMPLE OBESITY].
    Minerva medica, 1964, Feb-21, Volume: 55

    Topics: 17-Ketosteroids; Adrenocorticotropic Hormone; Fasting; Humans; Ketones; Metabolism; Metyrapone; Mine

1964